Abstract
Introduction
Phyllodes tumors of the breast are uncommon, and it is difficult to predict biologic behavior based on clinicopathologic features. Despite the wealth of data on the factors to predict recurrence, little is known about the impact of treatment refinements. This study seeks to define changes in patient characteristics, histopathologic parameters, and outcome between the two periods before and after the care of patients with breast diseases was centralized to a breast specialty.
Methods
The records of 182 patients with phyllodes tumors managed surgically were reviewed. Patients treated from 1985 to 1996 (n = 81) were compared with those seen from 1997 to 2004 (n = 101).
Results
The analysis of the two treatment periods revealed that there was a decrease in tumor size at diagnosis, from 7.7 cm during the earlier period to 4.6 cm during the recent period (P = 0.003). The patients undergoing breast-conserving surgery were significantly increased during the recent period. In contrast, pathologic features and local recurrence rates remained unchanged during the study period. Multivariate analysis revealed that positive surgical margin was the only independent predictor of recurrence, with an increased hazard of 8.0. Overall, upgrading to the next grade was observed in 16% of recurrences.
Conclusions
Breast-conserving surgery with clear margins is the current treatment of choice for phyllodes tumors, but this strategy does not further reduce local recurrence effectively. Optimal management continues to be a challenge.
Similar content being viewed by others
References
World Health Organization. Histological typing of breast tumors. Tumori 1982;68:181–198
Treves N. A study of cystosarcoma phyllodes. Ann NY Acad Sci 1964;114:922–936
Vorherr H, Vorherr UF, Kutvirt DM, et al. Cystosarcoma phyllodes: epidemiology, pathohistology, pathobiology, diagnosis, therapy, and survival. Arch Gynecol 1985;236:173–181
Parker SJ, Harries SA. Phyllodes tumours. Postgrad Med J 2001;77:428–435
Khan SA, Badve S. Phyllodes tumors of the breast. Curr Treat Options Oncol 2001;2:139–147
Azzopardi JG. Problems in breast pathology. In Bennington J, editor, Major Progress in Pathology. Philadelphia, Saunders, 1979;346–365
Kuijper A, Buerger H, Simon R, et al. Analysis of the progression of fibroepithelial tumours of the breast by PCR-based clonality assay. J Pathol 2002;197:575–581
Kuijper A, van der Groep P, van der Wall E, et al. Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast. Breast Cancer Res 2005;7:R808–R818
Sawyer EJ, Hanby AM, Rowan AJ, et al. The Wnt pathway, epithelial-stromal interactions, and malignant progression in phyllodes tumours. J Pathol 2002;196:437–444
Grimes MM. Cystosarcoma phyllodes of the breast: histologic features, flow cytometric analysis, and clinical correlations. Mod Pathol 1992;5:232–239
Hawkins RE, Schofield JB, Fisher C, et al. The clinical and histologic criteria that predict metastases from cystosarcoma phyllodes. Cancer 1992;69:141–147
Kleer CG, Giordano TJ, Braun T, et al. Pathologic, immunohistochemical, and molecular features of benign and malignant phyllodes tumors of the breast. Mod Pathol 2001;14:185–190
Hajdu SI, Espinosa MH, Robbins GF. Recurrent cystosarcoma phyllodes: a clinicopathologic study of 32 cases. Cancer 1976;38:1402–1406
Pietruszka M, Barnes L. Cystosarcoma phyllodes: a clinicopathologic analysis of 42 cases. Cancer 1978;41:1974–1983
Salvadori B, Cusumano F, Del Bo R, et al. Surgical treatment of phyllodes tumors of the breast. Cancer 1989;63:2532–2536
Norris HJ, Taylor HB. Relationship of histologic features to behavior of cystosarcoma phyllodes: analysis of ninety-four cases. Cancer 1967;20:2090–2099
Chen WH, Cheng SP, Tzen CY, et al. Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases. J Surg Oncol 2005;91:185–194
Ward RM, Evans HL. Cystosarcoma phyllodes: a clinicopathologic study of 26 cases. Cancer 1986;58:2282–2289
Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457–481
Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977;35:1–39
Cox DR. Regression models and life tables. J R Stat Soc [B] 1972;34:187–220
Bernstein L, Deapen D, Ross RK. The descriptive epidemiology of malignant cystosarcoma phyllodes tumors of the breast. Cancer 1993;71:3020–3024
Young JL Jr, Ward KC, Wingo PA, et al. The incidence of malignant non-carcinomas of the female breast. Cancer Causes Control 2004;15:313–319
Chua CL, Thomas A, Ng BK. Cystosarcoma phyllodes—Asian variations. Aust N Z J Surg 1988;58:301–305
Alagaratnam TT, Wong J. Benign breast disorders in nonwestern populations Part I. Benign breast disorders in Chinese women. World J Surg 1989;13:743–745
Tan PH, Jayabaskar T, Chuah KL, et al. Phyllodes tumors of the breast: the role of pathologic parameters. Am J Clin Pathol 2005;123:529–540
Blichert-Toft M, Hansen JP, Hansen OH, et al. Clinical course of cystosarcoma phyllodes related to histologic appearance. Surg Gynecol Obstet 1975;140:929–932
Palmer ML, De Risi DC, Pelikan A, et al. Treatment options and recurrence potential for cystosarcoma phyllodes. Surg Gynecol Obstet 1990;170:193–196
Rosen PP, Urban JA. Coexistent mammary carcinoma and cystosarcoma phyllodes. Breast 1975;1:9–15
Grove A, Deibjerg Kristensen L. Intraductal carcinoma within a phyllodes tumor of the breast: a case report. Tumori 1986;72:187–190
Knudsen PJ, Ostergaard J. Cystosarcoma phylloides with lobular and ductal carcinoma in situ. Arch Pathol Lab Med 1987;111:873–875
Chaney AW, Pollack A, McNeese MD, et al. Adjuvant radiotherapy for phyllodes tumor of breast. Radiat Oncol Invest 1998;6:264–267
Umekita Y, Yoshida H. Immunohistochemical study of hormone receptor and hormone-regulated protein expression in phyllodes tumour: comparison with fibroadenoma. Virchows Arch 1998;433:311–314
Kersting C, Kuijper A, Schmidt H, et al. Amplifications of the epidermal growth factor receptor gene (EGFR) are common in phyllodes tumors of the breast and are associated with tumor progression. Lab Invest 2006;86:54–61
Acknowledgments
One of the authors (C.L.L.) was supported by grants from the National Science Council of Taiwan and the Good-Neighbor Medical Research Foundation, Mackay Memorial Hospital, Taipei, Taiwan.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cheng, SP., Chang, YC., Liu, TP. et al. Phyllodes Tumor of the Breast: The Challenge Persists. World J. Surg. 30, 1414–1421 (2006). https://doi.org/10.1007/s00268-005-0786-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-005-0786-2